Among them, we selected KLLN for further investigation, for that it has been identified as a p53‐dependent tumor suppressor or an inducer of S and G2 phase checkpoint control.[38, 39] Gene Set Enrichment Analysis (GSEA) revealed that these DEGs were enriched for genes regulated by p53 (Figure 4B). The gene discussed is KLLN; the disease is neoplasm.